secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2025-12-10T23:59:59+00:00
Accession:  0001213900-25-120129
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma subsidiary to acquire captopril microcapsule patent for $6.3M in stock
--------------------------------------------------------------------------------

- Hainan Helpson subsidiary to receive Captopril microcapsule invention patent and preparation method from Lijie Tang.
- Transfer price of $6.3 million paid via 3,500,000 shares of CPHI common stock at $1.80 per share.
- Transferor to provide technical services including product R&D, registration materials, and application support.
- Shares issued as unregistered securities under Regulation S to a non-U.S. person.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390025120129/0001213900-25-120129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390025120129/ea026901601-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-120129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer